55 related articles for article (PubMed ID: 20520642)
1. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.
Zak Z; Gelebart P; Lai R
Leukemia; 2010 Aug; 24(8):1476-86. PubMed ID: 20520642
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis.
Gallucci GM; Alsuwayt B; Auclair AM; Boyer JL; Assis DN; Ghonem NS
Inflammation; 2022 Dec; 45(6):2570-2581. PubMed ID: 35838934
[TBL] [Abstract][Full Text] [Related]
3. Novel targeted therapies for mantle cell lymphoma.
Alinari L; Christian B; Baiocchi RA
Oncotarget; 2012 Feb; 3(2):203-11. PubMed ID: 22361516
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells.
Gelebart P; Eriksen Gjerstad M; Benjaminsen S; Han J; Karlsen I; Safont MM; Leitch C; Fandalyuk Z; Popa M; Helgeland L; Papp B; Baran-Marszak F; McCormack E
Blood; 2023 Oct; 142(17):1478-1493. PubMed ID: 37339584
[TBL] [Abstract][Full Text] [Related]
5. Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.
Wang Y; Habermann TM; Wang SS; Maurer MJ; Sarangi V; Link BK; Feldman AL; Inwards DJ; Witzig TE; Cozen W; Rothman N; Asmann Y; Slager SL; Cerhan JR
Am J Hematol; 2019 Jun; 94(6):E153-E155. PubMed ID: 30815899
[No Abstract] [Full Text] [Related]
6. Repositioning of the Antihyperlipidemic Drug Fenofibrate for the Management of
Guerra RM; Figueras MJ; Pujol-Bajador I; Fernández-Bravo A
Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543516
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Difluorinated Alkoxy Sulfonyl Chloride as a Novel Antitumor Agent for Hepatocellular Carcinoma through Activating Fumarate Hydratase Activity.
Jin J; Liang X; Bi W; Liu R; Zhang S; He Y; Xie Q; Liu S; Xiao JC; Zhang P
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139831
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia.
Xie C; Zhou H; Qin D; Zheng H; Tang Y; Li W; Zhou J; Liu L; Yu X; Duan H; Zhou Y; Li Z; Fang Z; Luo Y; Carter BZ; Xu B; Zha J
Cell Death Dis; 2023 Aug; 14(8):573. PubMed ID: 37644011
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
Wagner N; Wagner KD
Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing by Tumor Tissue Editing.
Lüke F; Harrer DC; Pantziarka P; Pukrop T; Ghibelli L; Gerner C; Reichle A; Heudobler D
Front Oncol; 2022; 12():900985. PubMed ID: 35814409
[TBL] [Abstract][Full Text] [Related]
11. Synergy Between Low Dose Metronomic Chemotherapy and the pH-centered Approach Against Cancer.
Koltai T; Cardone RA; Reshkin SJ
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683667
[TBL] [Abstract][Full Text] [Related]
12. Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal Carcinoma.
Morinishi T; Tokuhara Y; Ohsaki H; Ibuki E; Kadota K; Hirakawa E
PPAR Res; 2019; 2019():7486727. PubMed ID: 31354797
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel.
Luty M; Piwowarczyk K; Łabędź-Masłowska A; Wróbel T; Szczygieł M; Catapano J; Drabik G; Ryszawy D; Kędracka-Krok S; Madeja Z; Siedlar M; Elas M; Czyż J
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30641904
[TBL] [Abstract][Full Text] [Related]
14. NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
Balaji S; Ahmed M; Lorence E; Yan F; Nomie K; Wang M
J Hematol Oncol; 2018 Jun; 11(1):83. PubMed ID: 29907126
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Properties of Fenofibrate: A Repurposing Use.
Lian X; Wang G; Zhou H; Zheng Z; Fu Y; Cai L
J Cancer; 2018; 9(9):1527-1537. PubMed ID: 29760790
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2.
Cheng Y; Wei Z; Xie S; Peng Y; Yan Y; Qin D; Liu S; Xu Y; Li G; Zhang L
Mol Ther Nucleic Acids; 2017 Dec; 9():195-206. PubMed ID: 29246298
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy.
Gou Q; Gong X; Jin J; Shi J; Hou Y
Oncotarget; 2017 Sep; 8(36):60704-60709. PubMed ID: 28948004
[TBL] [Abstract][Full Text] [Related]
18. Anticancer activity of salicin and fenofibrate.
Sabaa M; ELFayoumi HM; Elshazly S; Youns M; Barakat W
Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):1061-1071. PubMed ID: 28733879
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.
Jan CI; Tsai MH; Chiu CF; Huang YP; Liu CJ; Chang NW
Int J Biol Sci; 2016; 12(7):786-98. PubMed ID: 27313493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
